Best mRNA / LNP CDMOs by Signal Score

← All mRNA/LNP CDMOs Best Clean FDA History Commercial Scale

CDMOs tracked

Fully scored

With FDA records

FDA inspections

EMA/MHRA GMP certs

mRNA and lipid nanoparticle (LNP) manufacturing scaled rapidly after COVID-19 vaccines and now supports therapeutics across rare disease, oncology, and infectious disease. The platform pairs IVT mRNA synthesis with LNP formulation — two distinct capability sets.

Choosing an mRNA/LNP CDMO depends on IVT scale, template strategy (linearized plasmid vs PCR), LNP formulation and microfluidics, and cold-chain handling. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.

FDA inspection outcomes across these CDMOs: 7 NAI (no action), 4 VAI (voluntary action), 0 OAI (official action). Leading inspection & GMP sites: Germany (23), Ireland (13), Denmark (12), UNITED KINGDOM (10), United States (9).

Last updated 2026-06-23. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

#	CDMO	Signal Score	Quality	FDA · GMP	Capacity	Programs
1	PC Pfizer CentreOne Kalamazoo, MI · McPherson, KS	91.5	100.0	4 insp · 17 GMP	—	363 programs
2	RP ReciBioPharm Keele, UK · Sodertalje, SE	88.0	100.0	0 insp · 3 GMP	—	0 programs
3	AE Aldevron Fargo, ND	85.3	100.0	1 insp · 0 GMP	—	0 programs
4	BNT BioNTech (Mfg Services) Mainz, DE · Marburg, DE	84.8	100.0	0 insp · 8 GMP	—	24 programs
5	FD FUJIFILM Diosynth Biotechnologies Research Triangle, NC · Holly Springs, NC · Hillerod, DK	83.5	100.0	0 insp · 18 GMP	Expanding	0 programs
6	CD Corden Pharma Plankstadt, DE · Caponago, IT · Boulder, CO	82.5	99.7	2 insp · 9 GMP	—	0 programs
7	MR Moderna (Contract Mfg) Norwood, MA	81.8	100.0	2 insp · 3 GMP	—	10 programs
8	MK Merck KGaA / MilliporeSigma (CDMO) Darmstadt, DE · St. Louis, MO	81.8	98.6	2 insp · 2 GMP	—	22 programs
9	WK Wacker Biotech Jena, DE · Amsterdam, NL · San Diego, CA	81.6	100.0	0 insp · 13 GMP	—	0 programs
10	DH Danaher (CGT Portfolio) Washington, DC	81.5	—	—	—	0 programs

How we score CDMOs →

What to evaluate in a mRNA / LNP CDMO

IVT mRNA synthesis

Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost.

LNP formulation

LNP encapsulation via microfluidics determines potency and tolerability. Confirm lipid sourcing, formulation freedom-to-operate, and particle-size control.

Plasmid / starting material

mRNA needs a DNA template. Check whether the CDMO supplies GMP plasmid in-house or coordinates a plasmid CDMO — it affects timelines.

Cold chain & stability

mRNA-LNP products are temperature-sensitive. Evaluate frozen storage, fill-finish, and the stability program.

mRNA / LNP CDMOs — Frequently Asked Questions

Who are the top mRNA / LNP CDMOs?

By CDMO Signal's independent Signal Score, the top-ranked mRNA / LNP CDMOs include Pfizer CentreOne, ReciBioPharm, Aldevron. See the full ranked table above — scored on FDA, clinical, financial, and capacity data.

How many mRNA / LNP CDMOs have FDA inspection records?

CDMO Signal tracks 5 mRNA / LNP CDMOs with FDA inspection records and 73 EMA/MHRA GMP certificates across the group.

What should I look for in an mRNA / LNP CDMO?

Look for proven IVT mRNA synthesis at your scale, LNP formulation via microfluidics, a clear template/plasmid supply strategy, cold-chain capability, and a clean FDA and EMA/MHRA record.

Do mRNA CDMOs also make the LNP and plasmid?

Capabilities vary. Some CDMOs offer end-to-end IVT mRNA, LNP formulation, and GMP plasmid; others specialize in one step and coordinate partners. Check each profile's modality coverage above.

Related modalities

Plasmid DNA CDMOs Lentiviral Vector CDMOs AAV / Gene Therapy CDMOs

Other Modalities

AAV CAR-T Lentiviral Cell Therapy Plasmid DNA Biologics Oligo/ASO Adenoviral Gene Editing Exosome Recombinant Proteins ADC